Close
13/12/2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
 
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.
 

More news

24/07/2015 CVC: 20 Years Making Images Meaningful 17/07/2015 Presentation of the Industrial Ring 4.0 Project 13/07/2015 New International Success for B-Barcelona Consulting /BGC 02/07/2015 Creation of the Barcelona Institute of Science and Technology 26/06/2015 A Delegation From Porto Alegre Visits the Barcelona Synchrotron Park 17/06/2015 First light for PAU camera, designed to study dark energy
31 32 33 34 35 36 37 38 39 40 41